1 |
human aortic smooth muscle cells
(388 times)
|
Vascular Diseases (62 times)
|
VSMCs (45 times) HUVECs (33 times) NF-kappaB (21 times)
|
1991 Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells.
|
2 |
human aortic SMCs
(30 times)
|
Vascular Diseases (8 times)
|
SMCs (16 times) VSMCs (8 times) AD (3 times)
|
1995 Human Aortic Vascular Smooth Muscle Cells Digest Extracellular Matrix by Elaboration of Plasminogen Activators: Implications for Atherogenesis.
|
3 |
human ASM cells
(4 times)
|
Pulmonary Medicine (2 times)
|
ASM (4 times) EdU (1 time) HLMCs (1 time)
|
2006 Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes.
|
4 |
human ASMCs
(4 times)
|
Pulmonary Medicine (1 time)
|
ASMCs (3 times) PDGF (2 times) ASMC (1 time)
|
2012 Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?
|
5 |
human artery VSMCs
(1 time)
|
Molecular Biology (1 time)
|
LEAOD (1 time) VSMCs (1 time)
|
2020 TIM‑3 inhibits PDGF‑BB‑induced atherogenic responses in human artery vascular smooth muscle cells.
|
6 |
human blood vessel smooth muscle cells
(1 time)
|
Molecular Biology (1 time)
|
PDE3 (1 time) PDEs (1 time)
|
2000 Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
|